Skip to content

Global Life Sciences

    • Letter
    • A4

Sidley’s industry-recognized Tier 1 Global Life Science practice leverages integrated teams across regulatory, compliance, enforcement, litigation, corporate, and transactional practice groups to advise life sciences and healthcare clients throughout their lifecycle.

Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Corporate and Transactional
M&A, Private Equity, Licensing & Collaborations, ECVC, and Capital Markets
Regulatory and Compliance
Food, Drug and Medical Device and Healthcare Regulatory, cGMP Compliance, and Drug Pricing
Government Investigations and Enforcement
DOJ Civil & Criminal Investigations, EU Whistleblower, FDA Enforcement, and FCPA/Anti-Bribery
Litigation
IP, Product Liability, False Claims Act, and Regulatory Litigation
Industry Sectors
We represent a range of companies, including drug, biotech, and medtech manufacturers, healthcare providers and healthcare services companies, and professional associations
Life Sciences
Healthcare
Regions
From high-profile transactions to regulatory issues and complex litigation, collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

Corporate and Transactional

Licensing and Partnering
M&A
Capital Markets
Private Equity
Emerging Companies and Venture Capital
Restructuring

Regulatory and Compliance

FDA Regulatory and Compliance
Healthcare Regulatory and Compliance
GMP Compliance
Global Drug Pricing
EU Food, Drug and Medical Device Regulatory
FDA and CMS Engagement Strategies
Other Government Engagement Strategies
Clinical Trials and Pharmacovigilance
Privacy and Cybersecurity
SEC Regulatory
Antitrust and Competition
ESG and Sustainability
International Trade, Customs, and Economic Sanctions

Government Investigations and Enforcement

DOJ Civil and Criminal Investigations
FDA Enforcement
FCPA and Anti-Bribery
SEC Enforcement
EU Whistleblower

Litigation

Product Liability and Mass Torts
IP Litigation
False Claims Act Litigation
Administrative and Regulatory Litigation
Shareholder Litigation
Commercial Litigation and Disputes
Global Arbitration, Trade and Advocacy

Life Sciences

Pharmaceutical Drugs and Biologics
Medical Devices and Equipment
Development-Stage Life Sciences Companies
Cell and Gene Therapy
Digital Health and AI Technologies
Wholesalers and Distributors
Contract Manufacturers and Other Supply Chain Participants
gribusiness and Food
Animal Health
Cosmetics
Dietary Supplements and Over-the-Counter (OTC) Products
Medical Foods

Healthcare

Clinical and Molecular Diagnostic Laboratories
Hospitals, Health Systems, Physician Practices, and Specialty Healthcare Providers
Pharmacies
Telehealth and Telemedicine

Contacts

View Professionals

You have successfully set your edition to Global. Would you like to make this selection your default edition?

*Selecting a default edition will set a cookie.

This page is available in your default region.